| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 04/26/1989 | EP0313343A1 Method of purifying protein |
| 04/26/1989 | EP0313224A1 Human cell lines of epithelial lung adenocarcinoma origin, human proteins and methods |
| 04/26/1989 | EP0313156A1 SnRNP-A antigen and fragments thereof |
| 04/26/1989 | EP0313104A2 Purification, production and use of tumor necrosis factors |
| 04/26/1989 | EP0313009A2 Method of gene amplification for enhancing protein production in cultured animal cells |
| 04/26/1989 | EP0312996A2 Anti-human bcdf monoclonal antibody |
| 04/26/1989 | EP0312617A1 Method of obtaining polypeptides in cell-free translation system |
| 04/26/1989 | EP0312598A1 Peptide functioning to accelerate activation of protein c with thrombin |
| 04/26/1989 | EP0312540A1 Monoclonal antibodies to unreduced, nonenzymatically-glycated proteins. |
| 04/25/1989 | US4824782 DNA base sequence, method for preparing a recombinant plasmid including the DNA base sequence, and breeding method for enhancing the protein-secreting ability of a microorganism by introducing thereinto the recombinant plasmid |
| 04/25/1989 | CA1253093A1 Rabies vaccine and preparation process thereof |
| 04/25/1989 | CA1253092A1 Derivative of the tryptophan operon for expression of fused gene products |
| 04/25/1989 | CA1253090A1 Monoclonal anti-human breast cancer antibodies |
| 04/25/1989 | CA1253073A1 Antigenic preparations and isolation of such preparations |
| 04/24/1989 | EP0302925A4 A method for producing factor viii in high yield. |
| 04/24/1989 | EP0241539A4 Expression systems for overproduction of desired proteins. |
| 04/20/1989 | WO1989003430A1 Method to produce immunodiagnostic reagents |
| 04/20/1989 | WO1989003429A1 Recombinant avipox virus |
| 04/20/1989 | WO1989003399A1 Method of preparation and use for zona pellucida antigens and antibodies for sterilization and contraception |
| 04/20/1989 | WO1989003398A1 Human monoclonal antibody against candida |
| 04/20/1989 | WO1989003397A1 Mouse monoclonal antibodies raised to the t-cell line hsb-2 and t-cell chronic lymphocytic leukemia (t-cll) cells react with normal human t and b lymphocytes and monocytes |
| 04/20/1989 | WO1989003396A2 Antibodies to natural killer cell and non-specific cytotoxic cell receptor |
| 04/20/1989 | WO1989003222A1 Soluble human cd4 fragments and uses therefor |
| 04/20/1989 | WO1989001783A3 Recombinant antibody and method |
| 04/19/1989 | EP0312358A2 Method for promoting intramolecular disulfide bond formation in recombinant proteins contained in a denaturant solution |
| 04/19/1989 | EP0312346A2 E. coli sequence specific acid protease |
| 04/19/1989 | EP0312164A1 Purification of recombinant epstein-barr virus antigens from vero cells, yeast cells or L cells |
| 04/19/1989 | EP0312159A2 Method for producing hepatitis B virus proteins in yeast |
| 04/19/1989 | EP0192677B1 Processes for recovery of products from waxy barley |
| 04/18/1989 | CA1252948A1 Process for purifying proteins |
| 04/18/1989 | CA1252720A1 Vaccine for cytomegalovirus |
| 04/18/1989 | CA1252714A1 Diagnostic agent for heart disease and use thereof |
| 04/12/1989 | EP0311589A1 Modified tissue plasminogen activator |
| 04/12/1989 | EP0311492A2 Kit and immunoassay method applicable to whole cells |
| 04/12/1989 | EP0311228A2 Recombinant polypeptides and their uses, including assay for AIDS virus |
| 04/12/1989 | EP0311194A2 Process for antifungal fermentation product and culture |
| 04/12/1989 | EP0311193A2 Antifungal fermentation product |
| 04/12/1989 | EP0310719A1 Method for purification of antibodies |
| 04/12/1989 | CN1032367A Dna construction with preceding sequence of kluyveromyces x-factor directing heterologous polypeptide excretion |
| 04/11/1989 | US4820641 Monoclonal antibody capable of specifically distinguishing human hepato-carcinoma cells |
| 04/11/1989 | US4820638 Novel alpha interferon species produced by recombinant means |
| 04/11/1989 | US4820505 Detection of activated platelets with antibodies to thrombospondin |
| 04/11/1989 | CA1252256A1 Drain assembly with synthetic resin lock nut and coupling elements |
| 04/06/1989 | WO1989002935A1 Respiratory syncytial virus: vaccines and diagnostic assays |
| 04/06/1989 | WO1989002924A1 Vaccines for malaria |
| 04/06/1989 | WO1989002922A1 Adheson variants |
| 04/06/1989 | WO1989002917A1 Production of plasminogen activator from cells at which lectin is added to the culture medium |
| 04/06/1989 | WO1989002915A1 Human cell lines of epithelial lung adenocarcinoma origin, human proteins and methods |
| 04/06/1989 | WO1989002899A1 Monoclonal antibody that recognizes an epitope of the gamma chain of human t cell surface receptors |
| 04/06/1989 | WO1989001490A3 Biologically active molecules |
| 04/05/1989 | EP0310238A2 New physiologically active substances, probestin and prostatin and production thereof |
| 04/05/1989 | EP0310229A1 Selective amplification of target polynucleotide sequences |
| 04/05/1989 | EP0310178A1 Recovery of pres2+S antigen |
| 04/05/1989 | EP0310137A2 BAR1 secretion signal |
| 04/05/1989 | EP0310136A2 Macrophage-derived inflammatory mediator (MIP-1alpha and MIP-1beta) |
| 04/05/1989 | EP0310132A2 Immunoassay utilizing IgG capture antibody and multiple monoclonal antibody detection system |
| 04/05/1989 | EP0310056A2 Thymic stroma-derived T cell growth factor and process for its production |
| 04/05/1989 | EP0309983A2 Enzymatic process for peptide preparation, in particular of dipeptides, and device therefor |
| 04/05/1989 | EP0309879A2 Molecular cloning and expression of neutral protease genes |
| 04/05/1989 | EP0309746A1 Antimalaria vaccines |
| 04/05/1989 | EP0309569A1 Production of purified, biologically active, bacterially produced recombinant human csf-1 |
| 04/05/1989 | EP0309565A1 Subtilisin analogs. |
| 04/05/1989 | EP0309555A1 Immunogenic polypeptide and method for purifying it |
| 04/05/1989 | EP0309548A1 Human tissue factor related dna segments, polypeptides and antibodies |
| 04/04/1989 | US4818698 Polypeptides and preparation process thereof |
| 04/04/1989 | US4818688 Assays for antibody to hepatitis B core antigen |
| 04/04/1989 | US4818687 Affinity column and process for detection of low molecular weight toxic substances |
| 04/04/1989 | US4818684 Immunoassay; binding antibody to steroid complex |
| 04/04/1989 | CA1252046A1 Methods for oncogenic detection |
| 03/30/1989 | DE3731875A1 Gentechnische herstellung von neukombinierten plasmiden fuer die produktion von humanem adrenocorticotropen horman (acth) und davon abgeleiteten derivaten durch enzymatische spaltung primaer synthetisierter fusionsproteine Genetic manufacture of recombined plasmids for the production of human adrenocorticotropic horman (acth) and derived by enzymatic cleavage derivatives synthesized fusion proteins primaer |
| 03/30/1989 | DE3731874A1 Verfahren zur herstellung von peptiden durch spezifische spaltung von gentechnisch gewonnenen fusionsproteinen mit collagenasen Process for the preparation of peptides by specific cleavage of fusion proteins with genetically acquired collage noses |
| 03/29/1989 | EP0309237A1 A transient expression system for producing recombinant protein |
| 03/29/1989 | EP0309161A2 Antibiotic compounds |
| 03/29/1989 | EP0309111A2 A process for obtaining higher yields of unaggregated tissue plasminogen activator from cell culture |
| 03/29/1989 | EP0309050A1 Human insulin-like growth factor analogs with reduced binding to serum carrier proteins and their production in yeast |
| 03/29/1989 | EP0308936A2 Antibody heteroconjugates for the killing of HIV-infected cells |
| 03/29/1989 | EP0308716A2 Modified plasminogen activators |
| 03/29/1989 | EP0308475A1 Adjuvant for certain antimitotic chemicals, obtained from vibrio cholerae |
| 03/29/1989 | EP0308424A1 A novel protein, neuroleukin |
| 03/29/1989 | EP0152483B1 Process for producing peptide |
| 03/28/1989 | US4816567 Immunology, vectors, dna |
| 03/28/1989 | US4816565 Interleukin 2 receptor and a method for production thereof |
| 03/28/1989 | US4816564 Method for producing hepatitis B virus proteins in yeast |
| 03/28/1989 | US4816559 Biologically active peptides TAN-866 |
| 03/28/1989 | US4816441 Anticarcinogenic agents, viricides |
| 03/28/1989 | US4816402 Murine hybridoma and diagnostic antibody produced thereby |
| 03/28/1989 | US4816398 Bivalent cations |
| 03/28/1989 | US4816397 Genetic engineering |
| 03/28/1989 | CA1251747A1 Monoclonal antibody to candida albicans cytoplasmic antigens and methods of preparing same |
| 03/23/1989 | WO1989002600A1 HUMAN ANTI-Rh(D) MONOCLONAL ANTIBODIES |
| 03/23/1989 | WO1989002472A1 Regulation of expression of gm-csf gene |
| 03/23/1989 | WO1989002467A1 Artificial gene coding for authentic human serum albumin, use thereof, and method of producing the same |
| 03/23/1989 | WO1989002465A2 Polypeptide production |
| 03/23/1989 | WO1989002463A1 Synthetic yeast leader peptides |
| 03/23/1989 | WO1989002462A1 Recombinant plasmids for producing human adrenocorticotropic hormone (acth) |
| 03/23/1989 | WO1989002461A1 Process for producing peptides by specific cleavage of fusion proteins with collagenases obtained by genetic engineering |
| 03/23/1989 | WO1989002443A1 HUMAN ANTI-Rh(D) MONOCLONAL ANTIBODIES |
| 03/23/1989 | WO1989002442A1 HUMAN ANTI-Rh(D) MONOCLONAL ANTIBODIES |
| 03/23/1989 | WO1989002441A1 Antibiotic compounds |
| 03/23/1989 | EP0222003A4 MOLECULAR CLONING OF cDNA FOR HUMAN FACTOR VIIIR (VON WILLEBRAND FACTOR). |